tradingkey.logo
搜索

GeneDx Holdings Corp

WGS
添加自选
71.710USD
+3.060+4.46%
收盘 07/01, 16:00美东报价延迟15分钟
2.13B总市值
亏损市盈率 TTM

GeneDx Holdings Corp

71.710
+3.060+4.46%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+4.46%

5天

+23.47%

1月

+37.93%

6月

-44.86%

今年开始到现在

-44.86%

1年

-22.32%

关键数据
69.000今开
71.760最高
721.60K成交量
亏损市盈率 TTM
51.33市盈率动
--股息TTM
2.43%换手率
68.650昨收
68.410最低
35.41M成交额
亏损市盈率静
8.37市净率
0.00%股息率 TTM
-16.33%ROA
170.87052周最高
0.65量比
-52.29M净利润
29.67M总股本
-2.6604每股收益TTM
1.99Beta
-30.42%ROE
32.21052周最低
4.88%振幅
66.71%毛利率
2.13B总市值
7.24回报/风险
4.03%风险率

TradingKey GeneDx Holdings Corp股票评分

单位: USD 更新时间: 2026-06-30

操作建议

GeneDx Holdings Corp当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗服务供应商行业排名13/76位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价89.56。中期看,股价处于平稳状态。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

GeneDx Holdings Corp评分

相关信息

行业排名
13 / 76
全市场排名
69 / 4569
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

GeneDx Holdings Corp亮点

亮点风险
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
业绩高增长
公司营业收入稳步增长,连续3年增长111.06%
估值低估
公司最新PE估值-25.80,处于3年历史低位
凯茜·伍德(木头姐)持仓
明星投资者凯茜·伍德(木头姐)持仓,最新持仓市值1.76M

分析师目标

根据 9 位分析师
买入
评级
89.556
目标均价
+30.45%
涨幅空间

GeneDx Holdings Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

GeneDx Holdings Corp简介

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
公司代码WGS
公司GeneDx Holdings Corp
CEOStueland (Katherine A)
网址https://sema4.com/

常见问题

GeneDx Holdings Corp(WGS)的当前股价是多少?

GeneDx Holdings Corp(WGS)的当前股价是 68.65。

GeneDx Holdings Corp的股票代码是什么?

GeneDx Holdings Corp的股票代码是WGS。

GeneDx Holdings Corp股票的52周最高点是多少?

GeneDx Holdings Corp股票的52周最高点是170.87。

GeneDx Holdings Corp股票的52周最低点是多少?

GeneDx Holdings Corp股票的52周最低点是32.21。

GeneDx Holdings Corp的市值是多少?

GeneDx Holdings Corp的市值是2.05B。

现在GeneDx Holdings Corp(WGS)的股票是买入、持有还是卖出?

根据分析师评级,GeneDx Holdings Corp(WGS)的总体评级为买入,目标价格为89.56。

GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是多少

GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是-0.73。